FDA guidelines – Page 32

Managing Powder Bridging in Tablet Press Hoppers

Managing Powder Bridging in Tablet Press Hoppers Managing Powder Bridging in Tablet Press Hoppers Introduction: In the realm of pharmaceutical manufacturing, the production of tablets represents a critical and intricate…

Root Cause Analysis of Failures in Weight Uniformity Tests

Root Cause Analysis of Failures in Weight Uniformity Tests Root Cause Analysis of Failures in Weight Uniformity Tests Introduction: In the realm of pharmaceutical manufacturing, ensuring the consistency and quality…

Managing Residual Solvents in Solvent-Based Coating Applications

Managing Residual Solvents in Solvent-Based Coating Applications Managing Residual Solvents in Solvent-Based Coating Applications Introduction: The use of solvent-based coatings in the pharmaceutical industry plays a crucial role in enhancing…

Managing Powder Segregation During Blending for Immediate Release Tablets

Managing Powder Segregation During Blending for Immediate Release Tablets Managing Powder Segregation During Blending for Immediate Release Tablets Introduction: The pharmaceutical industry constantly strives to ensure the production of high-quality…

Addressing Over-Lubrication in Powder Blends During Compression

Addressing Over-Lubrication in Powder Blends During Compression Addressing Over-Lubrication in Powder Blends During Compression Introduction: In the pharmaceutical industry, the production of high-quality tablets is pivotal. The tablet compression process…

Troubleshooting Residual Solvent Levels in Coated Tablets

Troubleshooting Residual Solvent Levels in Coated Tablets Troubleshooting Residual Solvent Levels in Coated Tablets Introduction: Residual solvents in coated tablets are a significant concern in pharmaceutical manufacturing due to their…

Optimizing Compression Force for Extended Release Tablet Uniformity

Optimizing Compression Force for Extended Release Tablet Uniformity Optimizing Compression Force for Extended Release Tablet Uniformity Introduction: Extended release tablets are a vital component of modern pharmaceutical therapies, designed to…

Poor validation of capsule transparency for certain formulations.

Poor validation of capsule transparency for certain formulations. Poor validation of capsule transparency for certain formulations. Introduction: In the pharmaceutical industry, the transparency of capsules, especially gelatin-based ones, plays a…

Ensuring GMP Compliance in Documentation for Cleaning Validation

Ensuring GMP Compliance in Documentation for Cleaning Validation Ensuring GMP Compliance in Documentation for Cleaning Validation Introduction: In the pharmaceutical industry, Good Manufacturing Practice (GMP) compliance is crucial to ensure…

Identifying Root Causes of Non-Uniform Coating Thickness in Tablets

Identifying Root Causes of Non-Uniform Coating Thickness in Tablets Identifying Root Causes of Non-Uniform Coating Thickness in Tablets Introduction: In the pharmaceutical industry, the coating of tablets is a critical…

Addressing Challenges in Process Validation for Immediate Release Tablets

Addressing Challenges in Process Validation for Immediate Release Tablets Addressing Challenges in Process Validation for Immediate Release Tablets Introduction: Immediate release tablets are a cornerstone in the pharmaceutical industry, known…

Preventing Non-Uniform Thickness in Enteric-Coated Tablet Layers

Preventing Non-Uniform Thickness in Enteric-Coated Tablet Layers Preventing Non-Uniform Thickness in Enteric-Coated Tablet Layers Introduction: In the pharmaceutical industry, enteric-coated tablets are designed to withstand the acidic environment of the…